Similarly, our previous study demonstrated that the genetic ablation of AR in prostate epithelial cells promoted the development of invasive PCa tumours (Niu et al, 2008), suggesting therapeutic suppressing androgen/AR function may elicit unwanted signals that may favour the progression of surviving PCa cells to the advanced stage. This evidence concerns the gene AR and neoplasm.